SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC Trademark

Trademark Overview


On Thursday, October 1, 2015, a trademark application was filed for SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC with the United States Patent and Trademark Office. The USPTO has given the SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC trademark a serial number of 86774708. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 23, 2022. This trademark is owned by Intercept Pharmaceuticals, Inc.. The SUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC trademark is filed in the Insurance & Financial Services category with the following description:

providing funding, support and/or financial assistance for research, studies and/or programs related to disease and treatments
supporting innovation to enhance future care in pbc

General Information


Serial Number86774708
Word MarkSUPPORTING INNOVATION TO ENHANCE FUTURE CARE IN PBC
Filing DateThursday, October 1, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 23, 2022
Registration Number4972479
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements


Goods and Servicesproviding funding, support and/or financial assistance for research, studies and/or programs related to disease and treatments

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 23, 2022
Primary Code036
First Use Anywhere DateFriday, November 13, 2015
First Use In Commerce DateFriday, November 13, 2015

Trademark Owner History


Party NameIntercept Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10011

Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10011

Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10011

Trademark Events


Event DateEvent Description
Friday, December 23, 2022CANCELLED SEC. 8 (6-YR)
Monday, June 7, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, September 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 7, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 8, 2016ASSIGNED TO LIE
Tuesday, January 12, 2016NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, January 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 11, 2016USE AMENDMENT ACCEPTED
Monday, January 11, 2016EXAMINER'S AMENDMENT ENTERED
Monday, January 11, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 11, 2016EXAMINERS AMENDMENT E-MAILED
Monday, January 11, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, January 8, 2016ASSIGNED TO EXAMINER
Thursday, December 17, 2015AMENDMENT TO USE PROCESSING COMPLETE
Thursday, December 17, 2015USE AMENDMENT FILED
Wednesday, December 16, 2015TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 5, 2015NEW APPLICATION ENTERED